In vivo inhibition of SREBP in mouse assessed as reduction in ACC1 mRNA level in liver at 10 mg/kg, ip administered once daily for 4 days by RT-PCR analysis
In vivo inhibition of SREBP in mouse assessed as reduction in FASN mRNA level in liver at 10 mg/kg, ip administered once daily for 4 days by RT-PCR analysis
In vivo inhibition of SREBP in mouse assessed as reduction in SCD1 mRNA level in liver at 10 mg/kg, ip administered once daily for 4 days by RT-PCR analysis
In vivo inhibition of SREBP in mouse assessed as reduction in PCSK9 mRNA level in liver at 10 mg/kg, ip administered once daily for 4 days by RT-PCR analysis
Inhibition of SREBP (unknown origin) expressed in CHO-K1 cells assessed as reduction in precursor SREBP protein level at 5 uM after 24 hrs by Western blotting analysis
Inhibition of SREBP (unknown origin) expressed in CHO-K1 cells assessed as reduction in mature SREBP protein level at 5 uM after 24 hrs by Western blotting analysis
Inhibition of FLAG-tagged SCAP (unknown origin) expressed in CHO-K1 cells assessed as reduction in SCAP protein level at 5 uM after 24 hrs by Western blotting analysis
Inhibition of SREBP (unknown origin) expressed in CHO-K1 cells assessed as reduction in precursor SREBP protein level at 1 uM after 24 hrs by Western blotting analysis
Inhibition of SREBP (unknown origin) expressed in CHO-K1 cells assessed as reduction in mature SREBP protein level at 1 uM after 24 hrs by Western blotting analysis
Inhibition of FLAG-tagged SCAP (unknown origin) expressed in CHO-K1 cells assessed as reduction in SCAP protein level at 1 uM after 24 hrs by Western blotting analysis
Inhibition of FLAG-tagged SCAP (unknown origin) expressed in CHO-K1 cells assessed as reduction in SCAP protein level at 1 to 5 uM after 24 hrs in presence of proteasome inhibitor MG132 by Western blotting analysis